Destination Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$28.6K 345
2025
Q4
$28.6K Buy
+100
New +$95.6K ﹤0.01% 300

Other funds holding LLY

Destination Wealth Management's LLY Position: Q1 2026 in Review

Destination Wealth Management increased its Eli Lilly (LLY) stake by 0.18% in Q1 2026, buying an estimated $103K and bringing the position to 56,684 shares worth $52.1M. The position accounts for 1.35% of the portfolio, ranked #27.

Destination Wealth Management first reported a position in LLY in Q2 2015 and has held it in 31 quarters since. The position peaked at $60.8M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Destination Wealth Management held 56,684 shares of Eli Lilly worth $52.1M as of Q1 2026.
  • Destination Wealth Management bought 102 Eli Lilly shares in Q1 2026, an estimated $103K.
  • Eli Lilly made up 1.35% of Destination Wealth Management's portfolio in Q1 2026, its #27 holding.
  • Destination Wealth Management first reported a position in Eli Lilly in Q2 2015 and has held it in 31 quarters since.
  • Destination Wealth Management's Eli Lilly position peaked at $60.8M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Destination Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.